SymbioTec (Germany) Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $43.7K

  • Investors
  • 1

SymbioTec (Germany) General Information

Description

Developer of medicines for cancer and infectious diseases. The company develops and markets pharmaceutical products for therapy and diagnostics of life-threatening diseases. It produces and sales medicines focused on treatment of acute lymphocytic and myeloid leukaemia.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • Science Park Saar 1
  • 66123 Saarbrucken
  • Germany
+49 0681 00000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SymbioTec (Germany) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 01-Nov-2022 $43.7K Completed Generating Revenue
4. Merger/Acquisition 17-Jan-2012 000.00 00.00 000.00 Completed Generating Revenue
3. Later Stage VC 15-Mar-2011 00.00 Completed Generating Revenue
2. Later Stage VC 18-Aug-2009 $1.4M $1.4M 00.00 Completed Generating Revenue
1. Early Stage VC 01-Jan-2001 Completed Startup
To view SymbioTec (Germany)’s complete valuation and funding history, request access »

SymbioTec (Germany) Executive Team (2)

Name Title Board Seat Contact Info
Michael Zeppezauer Co-Founder
You’re viewing 1 of 2 executive team members. Get the full list »

SymbioTec (Germany) Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Artgen biotech Corporation Minority 000 0000 000000 0
Gradus Venture Venture Capital Minority 000 0000 000000 0
To view SymbioTec (Germany)’s complete investors history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »